StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Humalog (insulin lispro) — U.S. revenue [legacy] by Quarter

Humalog (insulin lispro) — U.S. revenue ($M) [legacy] ($M)

QuarterlyAnnual

Eli Lilly Humalog (insulin lispro) — U.S. revenue [legacy]: $406M in Q4 2024, up 142.1% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2024
406
Period ended Dec 31, 2024
Change on a year earlier
+142.1%
168 in Q4 2023
History
32 quarters
Since Q1 2017
Sources
27
Documents cited below

Where the Q4 2024 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2025-02-19) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedHumalog (insulin lispro) — U.S. revenue ($M) [legacy] ($M)Year on yearSource
Q4 2024Dec 31, 2024406+142.1%Form 10-K (filed 2025-02-19) ↗
Q3 2024Sep 30, 2024324+66.8%Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024435+89.2%Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 2024338+24.6%Form 10-Q (filed 2024-04-30) ↗
Q4 2023Dec 31, 2023168-50.1%Form 10-K (filed 2025-02-19) ↗
Q3 2023Sep 30, 2023194-21.7%Form 10-Q (filed 2024-10-30) ↗
Q2 2023Jun 30, 2023230-3.8%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023272-26.4%Form 10-Q (filed 2024-04-30) ↗
Q4 2022Dec 31, 2022336+7.8%Form 10-K (filed 2025-02-19) ↗
Q3 2022Sep 30, 2022248-28.6%Form 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 2022239-27.4%Form 10-Q (filed 2023-08-08) ↗
Q1 2022Mar 31, 2022369+10.9%Form 10-Q (filed 2023-04-27) ↗
Q4 2021Dec 31, 2021312-24.9%Form 10-K (filed 2024-02-21) ↗
Q3 2021Sep 30, 2021347-11.0%Form 10-Q (filed 2022-11-01) ↗
Q2 2021Jun 30, 2021329+16.8%Form 10-Q (filed 2022-08-04) ↗
Q1 2021Mar 31, 2021333-16.5%Form 10-Q (filed 2022-04-29) ↗

Cite this data

StockData. (2026). Eli Lilly Humalog (insulin lispro) — U.S. revenue [legacy] ($M), quarterly Q1 2017–Q4 2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-humalog-us

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.